SEC Form 4 · accession 0001209191-15-049764
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph M Calabro
Officer — President and COO
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2015 | A | 53,412 | $0.00 | A | 306,797 | D | |
| Common StockF3 | Jun 1, 2015 | S | 37,918 | $70.4794 | D | 268,879 | D | |
| Common StockF4 | Jun 3, 2015 | S | 70,153 | $70.5199 | D | 198,726 | D | |
| Common Stock | holding | — | — | — | 8 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2016, June 1, 2017 and June 1, 2018.
- F2Sales of shares made pursuant to Reporting Person's 105b-1 trading plan.
- F3Sales made in ninety (90) separate transactions with prices ranging from $70.03 to $71.03 for a weighted average sales price of $70.4794.
- F4Sales of shares were made in eighty (80) separate transactions with prices ranging from $70.01 to $70.88 for a weighted average sales price of $70.5199.